Results found that BHMT silencing not only inhibited m6A modification on ATG3 mRNA but also attenuated the expression of ATG3 mRNA and protein in HCC cells, while SAM supplementation reversed those effects (Figure 6G-I). This evidence concerns the gene ATG3 and hepatocellular carcinoma.